HAWTHORNE, N.Y., May 22, 2009 (GLOBE NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,”) (Pink Sheets:TAROF) today announced that it has completed its internal review primarily of accounts receivable and inventory reserves estimates for prior years. Based on this review, the Company has concluded that it will restate previously issued 2004 and 2005 financial statements, which will also reflect adjustments to prior years (the “restatement”). The Company is also revising its previously announced unaudited and unreviewed estimates of its financial results for 2006, 2007 and 2008.
